Clinical Trial Update: DURABILITY-200: EverFlex 200mm Long Nitinol Stents in TASC C&D Femoropopliteal Lesions [Phase 4]

View source ↗

Summary

Phase 4 trial update showing completion of the DURABILITY-200 study evaluating EverFlex 200 mm nitinol stents in TASC C&D femoropopliteal lesions. The study tar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Intermittent Claudication
• Peripheral Vascular Disease

Snippet

Sponsor: Flanders Medical Research Program | Conditions: Peripheral Vascular Disease, Intermittent Claudication | Phase 4 | Status: COMPLETED